4.7 Article

Amplified detection of T4 polynucleotide kinase activity based on a λ-exonuclease cleavage-induced DNAzyme releasing strategy

Journal

SENSORS AND ACTUATORS B-CHEMICAL
Volume 192, Issue -, Pages 157-163

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2013.10.101

Keywords

T4 polynucleotide kinase; lambda-Exonuclease; Fluorescence sensor; DNAzyme

Funding

  1. National Natural Science Foundation of China [21005043, 21175076, 21375072]
  2. Scientific Special Expenditure for Non-profit Public Industry of State Oceanic Administration [201105020]
  3. Basic Research Program of Qingdao [13-1-4-214-jch]
  4. Science Foundation of China Postdoctor [2012M511537]

Ask authors/readers for more resources

The T4 polynucleotide kinase (T4 PNK) plays an essential role in the cellular responses to nucleic acid strand damage. Herein, a simple and sensitive fluorescence approach for monitoring T4 PNK activity was proposed based on a lambda-exonuclease (lambda-exo) cleavage-induced DNAzyme releasing strategy. A hairpin-shaped DNA probe that contains the sequence of 8-17 DNAzyme as a built-in suppressed catalytic unit was designed. After phosphorylation by T4 PNK followed with the immediate lambda-exonuclease (lambda-exo) cleavage, the 8-17 DNAzyme unit was successfully released and used for the cyclic cleavage toward the molecular beacon substrate, resulting in an evident fluorescence signal enhancement. With the currently developed lambda-exo cleavage reaction and DNAzyme-based platform, the amplified detection of 14 PNK with a low detection limit of 0.005 U mL(-1) could be achieved. Furthermore, the inhibition effects of adenosine diphosphate, ammonium sulfate, and sodium hydrogen phosphate have been evaluated. The developed lambda-exo cleavage-induced DNAzyme releasing strategy opens a promising avenue for monitoring activity and inhibition of nucleotide kinase, and should be also easily extended for the sensitive detection toward many other nucleic acid enzymes and may find widespread applications in biological process researches, drug discovery, and clinic diagnostics. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available